Article
Variability in plasma rifampicin concentrations and role of SLCO1B1, ABCB1, AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis.
Infectious diseases (London, England) - 1 Apr 2024
Sileshi Tesemma, Makonnen Eyasu, Telele Nigus Fikrie, Barclay Victoria, Zumla Alimuddin, Aklillu Eleni
Abstract excerpt
BACKGROUND: Rifampicin, a key drug against tuberculosis (TB), displays wide between-patient pharmacokinetics variability and concentration-dependent antimicrobial effect. We investigated variability in plasma rifampicin concentrations and the role of SLCO1B1, ABCB1, arylacetamide deacetylase (AADAC) and carboxylesterase 2 (CES-2) genotypes in Ethiopian patients with TB. METHODS: We enrolled adult patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
